26 Jul 2022 , 11:37 AM
Net profit of Glaxosmithkline Pharmaceuticals declined 1.49% to Rs 119.28 crore in the quarter ended June 2022 as against Rs 121.08 crore during the previous quarter ended June 2021. Sales rose 3.72% to Rs 745.10 crore in the quarter ended June 2022 as against Rs 718.37 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 745.10 | 718.37 | 4 |
| OPM % | 19.99 | 18.48 | – |
| PBDT | 178.90 | 177.46 | 1 |
| PBT | 163.08 | 159.92 | 2 |
| NP | 119.28 | 121.08 | -1 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
